Anti-oncogenic potential of the eIF4E-binding proteins

83Citations
Citations of this article
93Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The eIF4E-binding proteins (4E-BPs) are inhibitors of protein synthesis that sequester the mRNA cap-binding protein eIF4E and consequently block cell growth and proliferation. In most tumors however, their inhibitory function is compromised by major oncogenic signaling pathways. Recently, thanks to the generation of mouse genetic models, considerable progress has been made in elucidating the involvement of 4E-BPs and their unique target, eIF4E, in the process of carcinogenesis. Increasing evidence indicates that an 'addiction' to protein synthesis emerges in cancer cells, highlighting the potential that 4E-BPs have as targets for therapeutics. In this review, we summarize the biochemical function, regulation and anti-oncogenic activity of the 4E-BPs. © 2013 Macmillan Publishers Limited All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Martineau, Y., Azar, R., Bousquet, C., & Pyronnet, S. (2013, February 7). Anti-oncogenic potential of the eIF4E-binding proteins. Oncogene. https://doi.org/10.1038/onc.2012.116

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free